Trials / Completed
CompletedNCT01005550
Ropivacaine Hypobaric Spinal Anaesthesia in Traumatic Hip Surgery
Determining the Minimum Effective Ropivacaine Dose for Unilateral Hypobaric Spinal Anaesthesia During Traumatic Femoral Neck Surgery in the Aged Person: Prospective Comparative Randomized Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, monocentric, randomized study, comparing the effectiveness and tolerance of four different dosages of hypobaric ropivacaine for unilateral spinal anaesthesia during traumatic femoral neck surgery in the elderly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 6 mg of ropivacaine | 6 mg of ropivacaine are used for the spinal anaesthesia |
| DRUG | 8 mg of ropivacaine | 8 mg of ropivacaine are used for the spinal anaesthesia |
| DRUG | 10 mg of ropivacaine | 10 mg of ropivacaine for the spinal anaesthesia |
| DRUG | 12 mg of ropivacaine | 12 mg of ropivacaine for the spinal anaesthesia |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2009-11-02
- Last updated
- 2019-05-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01005550. Inclusion in this directory is not an endorsement.